Propanc Biopharma Inc
OTC:PPCB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Propanc Biopharma Inc
OTC:PPCB
|
AU |
|
Saranacentral Bajatama Tbk PT
IDX:BAJA
|
ID |
|
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
CA |
|
S
|
Shenzhen Edadoc Technology Co Ltd
SZSE:301366
|
CN |
|
Syensqo NV
F:2NF
|
BE |
|
N
|
North Long Dragon New Materials Tech Co Ltd
SZSE:301357
|
CN |
|
Autowave Co Ltd
TSE:2666
|
JP |
|
G
|
Glory Sun Land Group Ltd
HKEX:299
|
HK |
|
S
|
Stif France SAS
PAR:ALSTI
|
FR |
|
O
|
Ovation Science Inc
CNSX:OVAT
|
CA |
|
Big M Entertainment Corp
OTC:HQGE
|
US |
|
Fjord Defence Group ASA
OSE:DFENS
|
NO |
|
Americore Resources Corp
XTSX:AMCO
|
CA |
Propanc Biopharma Inc
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate PRP is a pharmaceutical composition consisting of two pancreatic proenzymes trypsinogen and chymotrypsinogen for treating cancer. PRP is an approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that targets and eradicates cancer stem cells in patients suffering from pancreatic, ovarian and colorectal cancers. PRP is a therapy based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas and could represent the body’s primary defense against cancer.
Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The firm has developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its lead product candidate PRP is a pharmaceutical composition consisting of two pancreatic proenzymes trypsinogen and chymotrypsinogen for treating cancer. PRP is an approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that targets and eradicates cancer stem cells in patients suffering from pancreatic, ovarian and colorectal cancers. PRP is a therapy based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas and could represent the body’s primary defense against cancer.
